How to Buy Flow Cytometers for Screening
Flow cytometry is a powerful technique that analyzes the physical characteristics of particles, usually cells, as they flow in a fluid stream through a beam of light. This guide highlights key considerations and expert tips for buying a new flow cytometer for drug discovery and screening applications, to ensure you get the best flow cytometry results.
Read the full guide...
Become a member
- Complete access to free Guides
-
Download 10,000+
applications and methods - Make informed buying decisions
Choose the best flow cytometer for your laboratory
In this exclusive guide, we present key factors and important considerations that can help guide your choice of flow cytometer for drug discovery and screening applications. Download the SelectScience how-to-buy eBook to find out more about:
- The key components of flow cytometry technology
- Screening applications of flow cytometry, including:
- Cell therapy
- Antibody discovery
- Multiplexing
- General considerations
- Expert advice
- The future of flow cytometry
Editor's Picks
Carrie HaslamEditorial
NovoCyte (Agilent Technologies)
“It is the most used instruments in our lab. Even undergrads can use the instrument”
Tamer Kahraman, THORVACS Biyoteknoloji LTD STI
ZE5 Cell Analyzer (Bio-Rad)
“Features rare cells, up to 100,000 events per second. Study populations and small particles with ease, Expand your panels with up to 27 bright colors”
Natália Ferreira, Laboratório De Mutagênese Unifran.
Navios Flow Cytometer (Beckman Coulter Life Sciences)
“I recommend it for the excellent performance of its flow cytometry.”
Francesca Ricci, Policlinic - University Of Bologna
MACSQuant® X Flow Cytometer (Miltenyi Biotec B.V. & Co. KG)
“We use the cytometer for general purposes and, specifically, to run high throughput screening assays for antibiotic and antifungic activity of natural...”
Alberto Alvarez-Barrientos, Universidad de Extremadura, Spain
FLEXMAP 3D® Multiplexing Instrument (Luminex)
“User friendly interface. Durable calibration and service”
Imad Tarhoni, Rush University Medical Center